Veracyte Inc (VCYT NASDAQ) stock market data APIs
$36.4669
-0.29(-0.8%)
as of October 24, 2025
Try our APIs with
free plan!
Veracyte Inc Financial Data Overview
Price chart is built with
Anychart
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It is also developing the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Prev. Close
36.4669
Open
36.1727
High
36.6569
Low
35.7393
52 wk Range
22.61-47.3162
Market Cap
2 890 M
P/E Ratio
108.0294
Shares Outstanding
78 672 K
Revenue
479 M
EPS
0.44
Beta
2.115
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Veracyte Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Veracyte Inc data using free add-ons & libraries
Get Veracyte Inc Fundamental Data
Veracyte Inc Fundamental data includes:
- Net Revenue: 479 M
- EBITDA: 63 779 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-06
- EPS/Forecast: 0.11
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Veracyte Inc News
New
ITGR Shares Down Despite Q3 Earnings & Revenues Beat Estimates
Integer Holdings Corporation ITGR delivered adjusted earnings per share (EPS) of $1.79 in the third quarter of 2025, which improved 25.2% year over year. The figure surpassed the Zacks Consensus Esti...
Cathie Wood Bets Millions On Robinhood And Netflix, Dumps AMD And Palantir
This article first appeared on GuruFocus. Oct 23 - Cathie Wood's ARK ETFs Made Large Bets In Fintech And Media While Trimming Semiconductors, According To Wednesday Trade Filings. The firm bought 16...
ISRG Stock Gains on Q3 Earnings & Revenue Beat, Gross Margin Declines
Intuitive Surgical ISRG reported third-quarter 2025 adjusted earnings per share (EPS) of $2.40, which beat the Zacks Consensus Estimate of $1.99 by 20.6%. The bottom line improved 30.4% year over year...
Boston Scientific Beats on Q3 Earnings, Raises 2025 View, Stock Up
Boston Scientific Corporation BSX posted third-quarter 2025 adjusted earnings per share (EPS) of 75 cents, up 19% from the year-ago figure. The figure beat the Zacks Consensus Estimate by 5.6% and exc...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
